Senior Immunologist

About the role

We have an exciting opportunity an exceptional Senior Immunologist to join the Oxford Vaccine Group (OVG) as part of the pioneering Correlates of Immunity – Artificial Intelligence (CoI-AI) Programme. This ambitious programme combines advanced immunology, artificial intelligence, and human challenge models to transform vaccine discovery and accelerate development against major bacterial pathogens including Streptococcus pneumoniae, Group A Streptococcus, Staphylococcus aureus, and Neisseria gonorrhoeae.

As Senior Immunologist, you will provide scientific and strategic leadership for human immunology activities across the programme. You will design, lead, and interpret cutting-edge immunological studies; develop and validate innovative humoral and cellular assays; and guide a multidisciplinary team to deliver high-quality, standardised datasets suitable for advanced AI analysis. You will play a key role in shaping the scientific direction of the programme, forging collaborations across academia, industry, and global health partners, and contributing to internationally recognised publications.

You will be working in a growing department within the Medical Sciences Division. The Department of Paediatrics is a world leader in child health research and hosts internationally renowned research programmes in drug development, gastroenterology, haematology, HIV, immunology, neuroimaging, neuromuscular diseases and vaccinology. The Oxford Vaccine Group is a world-leading academic research group conducting clinical and translational studies to advance vaccine development working with a diverse portfolio funded by industry, government and charitable organisations.

This position is offered full-time on a fixed-term contract initially for 4 years with the possibility to extend provided further external funding is available.

About you

You will hold a PhD/DPhil in Immunology or a related discipline, with extensive post-qualification experience and a strong record of innovation in translational or clinical immunology. You will bring a proven ability to lead large, complex research initiatives, manage multidisciplinary teams, and develop novel immunological methodologies. A track record of high-impact publications and demonstrated experience in human challenge and/or vaccine studies is essential.

Only online applications received before 12.00 midday on Monday 1st December 2025 will be considered. Interviews are planned to take place during the first week of January 2026.

Advert information